This study is a 21-day supervised in-use test with 20 volunteers, conducted under the joint oversight of a qualified dermatologist and ophthalmologist. The study includes comprehensive clinical evaluation and final sign-off from both specialists, providing robust data on product tolerance and performance for both skin and eye areas.
Products that are applied to the face—especially near the eyes—require evaluation across multiple exposure pathways. This dual-supervision study ensures that both dermal and ocular safety are assessed under realistic use conditions.
This study evaluates how a product performs when used under normal conditions on the skin and around the eye area. It focuses on:
It also helps determine whether repeated use may cause irritation, sensitivity, or discomfort in either area.
The study follows a controlled, supervised in-use design over 21 days at a clinical site.
This design ensures comprehensive safety assessment across intended use conditions.
Participants are selected based on the intended product use.
All participants:
This allows for accurate assessment of product-related effects.
Clinical and subjective assessments are conducted throughout the study.
Dermatological assessments may include:
Ophthalmological assessments may include:
Participants also provide feedback on:
Both clinical observations and user feedback contribute to the final evaluation.
This study can support a broad range of high-value marketing and safety claims, including:
Final claim support depends on study outcomes and regulatory considerations.
At the conclusion of the study:
The report is suitable for regulatory documentation, safety substantiation, and marketing support.
Pentyl Labs coordinates dual-supervision in-use testing with:
We also support related services such as HRIPT, safety assessments, and claims substantiation.
Contact [email protected] to request a Supervised In-Use Test under Dermatological & Ophthalmological Control.